米托蒽醌（二羟基蒽二酮）治疗晚期结直肠癌的II期研究。
Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinoma.
作者信息
DeSimone P A, Gams R, Bartolucci A
出版信息
Am J Clin Oncol. 1984 Oct;7(5):517-22. doi: 10.1097/00000421-198410000-00024.
Abstract
One hundred four patients with advanced colon carcinoma were treated with mitoxantrone 5 mg/m2 I.V. weekly. The patients were stratified into two groups: prior chemotherapy and no prior chemotherapy. Only one partial response was noted in the prior treatment category.
摘要
104例晚期结肠癌患者接受米托蒽醌5mg/m²静脉注射，每周一次治疗。患者被分为两组：曾接受过化疗和未接受过化疗。在曾接受过治疗的类别中仅观察到1例部分缓解。
Zotero 插件